» Authors » Nithya Lingampalli

Nithya Lingampalli

Explore the profile of Nithya Lingampalli including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 860
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jozefowski N, Eikani C, Lingampalli N, Lawler P, Barrett A, Hoyt A, et al.
OTA Int . 2025 Feb; 8(1):e361. PMID: 39901920
Purpose: Large-scale registry data efforts are common in orthopaedic surgery; however, there is wide variation between registries and little known about registry impact. The purpose of this study was to...
2.
Brown N, Lingampalli N, Schmitt D
Orthop Clin North Am . 2024 Nov; 56(1):29-34. PMID: 39581643
A multitude of factors influence implant choice in total joint replacement surgeries, including surgeon choice. Attempts at limiting health care costs by restricting implant choice have become commonplace. A spectrum...
3.
Brown N, Lingampalli N, Hellman M
Orthop Clin North Am . 2023 Nov; 55(1):27-32. PMID: 37980101
Total knee arthroplasty (TKA) is a widely accepted surgical procedure for managing end-stage knee osteoarthritis. Among the various TKA techniques, kinematic alignment has gained increasing popularity as it can potentially...
4.
Dy C, Lingampalli N, Peacock K, Olsen M, Ray W, Brogan D
J Hand Surg Glob Online . 2020 Sep; 2(2):77-79. PMID: 32864587
Purpose: The economic implications of brachial plexus injuries (BPI) in the United States are not well understood. The purpose of our study was to quantify the direct costs associated with...
5.
Kuerten S, Lanz T, Lingampalli N, Lahey L, Kleinschnitz C, Maurer M, et al.
Proc Natl Acad Sci U S A . 2020 Aug; 117(35):21512-21518. PMID: 32817492
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS), with characteristic inflammatory lesions and demyelination. The clinical benefit of cell-depleting therapies targeting CD20 has emphasized...
6.
Elliott S, Kongpachith S, Lingampalli N, Adamska J, Cannon B, Blum L, et al.
Clin Immunol . 2020 Feb; 212:108360. PMID: 32035179
Rheumatoid arthritis (RA) is characterized by the production of anti-citrullinated protein antibodies (ACPAs). To gain insights into the relationship between ACPA-expressing B cells in peripheral blood (PB) and synovial tissue...
7.
Wang Q, Onuma K, Liu C, Wong H, Bloom M, Elliott E, et al.
JCI Insight . 2019 Sep; 4(18). PMID: 31534047
Osteoarthritis (OA) is the leading cause of joint failure, yet the underlying mechanisms remain elusive, and no approved therapies that slow progression exist. Dysregulated integrin function was previously implicated in...
8.
Wang Q, Lepus C, Raghu H, Reber L, Tsai M, Wong H, et al.
Elife . 2019 May; 8. PMID: 31084709
Editorial Note: This article has been through an editorial process in which the authors decide how to respond to the issues raised during peer review. The Reviewing Editor's assessment is...
9.
ODonnell C, Migliore E, Grandi F, Koltsov J, Lingampalli N, Cisar C, et al.
J Orthop Res . 2019 May; 37(8):1760-1770. PMID: 31042308
There is intense clinical interest in the potential effects of platelet-rich plasma (PRP) for the treatment of osteoarthritis (OA). This study tested the hypotheses that (i) "lower" levels of the...
10.
Kongpachith S, Lingampalli N, Ju C, Blum L, Lu D, Elliott S, et al.
Arthritis Rheumatol . 2019 Feb; 71(4):507-517. PMID: 30811898
Objective: Anti-citrullinated protein antibodies (ACPAs) are a hallmark of rheumatoid arthritis (RA). While epitope spreading of the serum ACPA response is believed to contribute to RA pathogenesis, little is understood...